United States:
Holland & Knight Health Dose: February 28, 2023
07 March 2023
Holland & Knight
To print this article, all you need is to be registered or login on Mondaq.com.
Holland & Knight Health Dose is an in-depth weekly
dose of legislative and regulatory insights to keep stakeholders
abreast of happenings in Washington, D.C., impacting the health
sector.
This week's topics include:
- PAHPA Reauthorization RFI: Responses Due in Two Weeks
- Capitol Hill's Push for PBM Reform
- DEA Releases Proposed Rule to Scale Back COVID-Era Telehealth
Policies
- BPCI Advanced Model 2024 Application Portal Open
- PHE Expiration
Read the full Health Dose
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
ChatGPT And Privacy Risks
Sheppard Mullin Richter & Hampton
SINCE ITS LAUNCH in November 2022, ChatGPT (GPT stands for Generative Pre-trained Transformer), a type of artificial intelligence model, has gained over a million users.
Holland & Knight Health Dose: May 9, 2023
Holland & Knight
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
HHS Unveils New Cybersecurity Guide
Akin Gump Strauss Hauer & Feld LLP
The U.S. Department of Health and Human Services (HHS) continues to play a central role in helping health care organizations defend against cybersecurity threats...
